EKF Diagnostics Holdings Plc (EKF Diagnostics) is an in vitro diagnostics company that designs, develops, manufactures, and markets point-of-care (POC) devices and tests; and central laboratory products. Its POC range includes hemoglobin analyzers, glucose analyzers and HbA1c analyzers that can be used for screening, monitoring and diagnosing patients, and conducting tests for common infectious diseases and pregnancy, while its central laboratory range includes various clinical reagents and centrifuges. Its products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. The company sells its products through OEM partnerships with large distributors, and through agreements with local distributors in various countries. The company has offices in the UK, Germany, USA, Russia and China with a network of more than 200 distributors across various countries. EKF Diagnostics is headquartered in Penarth, Wales, the UK.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EKF Diagnostics Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- EKF Diagnostics Holdings Plc Company Overview
- EKF Diagnostics Holdings Plc Company Snapshot
- EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
- EKF Diagnostics Holdings Plc - Pipeline Analysis Overview
- Business Description
- EKF Diagnostics Holdings Plc - Key Facts
- EKF Diagnostics Holdings Plc - Major Products and Services
- EKF Diagnostics Holdings Plc Pipeline Products by Development Stage
- EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
- EKF Diagnostics Holdings Plc Pipeline Products Overview
- B-HB POC Analyser
- B-HB POC Analyser Product Overview
- BIOSEN HbA1c Instrument
- BIOSEN HbA1c Instrument Product Overview
- DiaSpect Tm
- DiaSpect Tm Product Overview
- FractalDx - Acute Transplant Rejection Diagnostic
- FractalDx - Acute Transplant Rejection Diagnostic Product Overview
- KidneyIntelX
- KidneyIntelX Product Overview
- KidneyIntelX Clinical Trial
- Lactate Scout 4 - Clinic Use
- Lactate Scout 4 - Clinic Use Product Overview
- Point-Of-Care Test - Coagulation
- Point-Of-Care Test - Coagulation Product Overview
- Point-Of-Care Test - Vitamin D Test
- Point-Of-Care Test - Vitamin D Test Product Overview
- PointMan Assay - Breast Cancer
- PointMan Assay - Breast Cancer Product Overview
- PointMan Assay - Lung Cancer
- PointMan Assay - Lung Cancer Product Overview
- PointMan Assay - Skin Cancer
- PointMan Assay - Skin Cancer Product Overview
- PointMan PI3K DNA Enrichment Kit
- PointMan PI3K DNA Enrichment Kit Product Overview
- Quo-Lab - C-Reactive Protein
- Quo-Lab - C-Reactive Protein Product Overview
- RenaStat
- RenaStat Product Overview
- SensPoint
- SensPoint Product Overview
- Serum/Plasma Analyser
- Serum/Plasma Analyser Product Overview
ß-Hydroxybutyrate LiquiColor Reagent Product Overview
- Xtract Liquid Phase Extraction Device
- Xtract Liquid Phase Extraction Device Product Overview
- EKF Diagnostics Holdings Plc - Key Competitors
- EKF Diagnostics Holdings Plc - Key Employees
- EKF Diagnostics Holdings Plc - Key Employee Biographies
- EKF Diagnostics Holdings Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- EKF Diagnostics Holdings Plc, Recent Developments
- Nov 30, 2022: Renalytix reports financial results for first quarter of fiscal year 2023
- Nov 22, 2022: Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
- Oct 31, 2022: Renalytix Reports Full Year Fiscal 2022 Results
- Oct 31, 2022: Renalytix Reports Full Year Fiscal 2022 Results
- Jun 30, 2022: Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
- Jun 23, 2022: Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30
- Jun 09, 2022: EKF Diagnostics Holdings : Launch of EKF Link
- Apr 25, 2022: EKF Diagnostics Holdings announces Posting of Annual Report & Accounts &Notice of AGM
- Mar 31, 2022: Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
- Mar 30, 2022: Renalytix announces Timothy Scannell appointed to the Board
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
- EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type
- EKF Diagnostics Holdings Plc Pipeline Products by Indication
- EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
- EKF Diagnostics Holdings Plc, Key Facts
- EKF Diagnostics Holdings Plc, Major Products and Services
- EKF Diagnostics Holdings Plc Number of Pipeline Products by Development Stage
- EKF Diagnostics Holdings Plc Pipeline Products Summary by Development Stage
- EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
- EKF Diagnostics Holdings Plc Ongoing Clinical Trials Summary
- B-HB POC Analyser - Product Status
- B-HB POC Analyser - Product Description
- BIOSEN HbA1c Instrument - Product Status
- BIOSEN HbA1c Instrument - Product Description
- DiaSpect Tm - Product Status
- DiaSpect Tm - Product Description
- FractalDx - Acute Transplant Rejection Diagnostic - Product Status
- FractalDx - Acute Transplant Rejection Diagnostic - Product Description
- KidneyIntelX - Product Status
- KidneyIntelX - Product Description
- KidneyIntelX - A Clinical Validation Study of AI-enabled KidneyIntelX for Diagnosing Fast-Progressing Kidney Disease
- KidneyIntelX - A Prospective Decision Impact Clinical Utility Trial of KidneyIntelX in Patients with Type 2 Diabetes and Existing Chronic Kidney Disease
- KidneyIntelX - A Prospective Decision Impact Trial of KidneyIntelX in Patients with Type 2 Diabetes and Existing Chronic Kidney Disease
- KidneyIntelX - A Prospective Decision Impact Trial of KidneyIntelX in Patients with Type II Diabetes and Existing Chronic Kidney Disease
- KidneyIntelX - Multi-center Assessment of Survivors for Kidney Disease after COVID-19 (MASKeD-COVID)
- KidneyIntelX - Prospective Clinical Utility Study of Kidneyintelx AI-enabled for the Diagnosis of Kidney Disease
- KidneyIntelX - Real World Evidence Clinical Utility Study of KidneyIntelX in Patients with Type 2 Diabetes and Chronic Kidney Disease
- KidneyIntelX - Study to Evaluate the Uptake and Adherence to New Potassium-binding Agents in Patients with Chronic Kidney Disease and Hyperkalemia
- Lactate Scout 4 - Clinic Use - Product Status
- Lactate Scout 4 - Clinic Use - Product Description
- Point-Of-Care Test - Coagulation - Product Status
- Point-Of-Care Test - Coagulation - Product Description
- Point-Of-Care Test - Vitamin D Test - Product Status
- Point-Of-Care Test - Vitamin D Test - Product Description
- PointMan Assay - Breast Cancer - Product Status
- PointMan Assay - Breast Cancer - Product Description
- PointMan Assay - Lung Cancer - Product Status
- PointMan Assay - Lung Cancer - Product Description
- PointMan Assay - Skin Cancer - Product Status
- PointMan Assay - Skin Cancer - Product Description
- PointMan PI3K DNA Enrichment Kit - Product Status
- PointMan PI3K DNA Enrichment Kit - Product Description
- Quo-Lab - C-Reactive Protein - Product Status
- Quo-Lab - C-Reactive Protein - Product Description
- RenaStat - Product Status
- RenaStat - Product Description
- SensPoint - Product Status
- SensPoint - Product Description
- Serum/Plasma Analyser - Product Status
- Serum/Plasma Analyser - Product Description
ß-Hydroxybutyrate LiquiColor Reagent - Product Description
- Xtract Liquid Phase Extraction Device - Product Status
- Xtract Liquid Phase Extraction Device - Product Description
- EKF Diagnostics Holdings Plc, Key Employees
- EKF Diagnostics Holdings Plc, Key Employee Biographies
- EKF Diagnostics Holdings Plc, Other Locations
- EKF Diagnostics Holdings Plc, Subsidiaries
- Glossary
- EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type
- EKF Diagnostics Holdings Plc Pipeline Products by Development Stage
- EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Siemens Healthineers AG
- Roche Diagnostics International Ltd
- Quidel Corp
- Qiagen NV
- Ortho Clinical Diagnostics Holdings Plc
- DiaSorin SpA
- Danaher Corp
- Bio-Rad Laboratories Inc
- bioMerieux SA
- Becton Dickinson and Co
